After being modified with DBCO-PEG4-NHS and subsequently labeled with a secondary antibody (targeting the Fc region), the antibody was found to be unable to bind to antigen-expressing cells. What could be the possible reasons for this

More Xiaoqian Niu's questions See All
Similar questions and discussions